NRGene Technologies Balance Sheet Health
Financial Health criteria checks 6/6
NRGene Technologies has a total shareholder equity of $7.2M and total debt of $905.0K, which brings its debt-to-equity ratio to 12.5%. Its total assets and total liabilities are $10.8M and $3.6M respectively.
Key information
12.5%
Debt to equity ratio
US$905.00k
Debt
Interest coverage ratio | n/a |
Cash | US$6.45m |
Equity | US$7.21m |
Total liabilities | US$3.57m |
Total assets | US$10.79m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: NRGN's short term assets ($7.2M) exceed its short term liabilities ($2.9M).
Long Term Liabilities: NRGN's short term assets ($7.2M) exceed its long term liabilities ($670.0K).
Debt to Equity History and Analysis
Debt Level: NRGN has more cash than its total debt.
Reducing Debt: NRGN had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NRGN has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: NRGN has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 28.8% each year.